Goals of Treatment
Treatment overview
Treatment for anemia associated with clonal hematopoiesis including MDS may consist of supportive care or active treatments, alone or in combination.Treating Myelodysplastic Syndromes. November 21, 2024. American Cancer Society. Accessed May 21, 2025. https://www.cancer.org/content/dam/CRC/PDF/Public/8746.00.pdf
While research has shown that earlier treatment initiation can improve outcomes in lower-risk MDS, many patients are left on watch-and-wait lists and remain untreated.Germing U et al. Hemasphere. 2019;3(6):e314.
Explore different treatment modalities and their goals below:
Figure referencesGerming U et al. Hemasphere. 2019;3(6):e314. Platzbecker U. Blood. 2019;133(10):1096-1107. Platzbecker U et al. Leukemia. 2021;35:2182-2198.
Treatment goals in MDSPlatzbecker U. Blood. 2019;133(10):1096-1107.
Treatment goals are dependent on patient and HCP priorities, as well as specific disease factors.
Learn more
